Pramlintide
Evaluation of the Effect of Pramlintide on Satiety and Food Intake
AstraZeneca · Phase 2 · Completed · Enrollment 51
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | T2D only | n/r | n/r | n/r | n/r |
| Pramlintide | T2D only | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Pramlintide
AstraZeneca · Phase 2 · Completed · Enrollment 51
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | T2D only | n/r | n/r | n/r | n/r |
| Pramlintide | T2D only | n/r | n/r | n/r | n/r |